COVID-19 Vaccine Induces SARS-CoV-2 Spike Glycoprotein-Specific CD4+ and CD8+ T-Cell Immunity, Which Is Significantly Decreased Six Months After the Administration of the Second Dose of the Vaccine. Here, CD8A is linked to COVID-19.